Prolira - DeltaScan®

medical devices

About

Prolira is a Dutch medical technology company focused on developing and commercializing the DeltaScan® Brain State Monitor. This innovative device is designed to detect acute brain failure conditions, such as delirium and acute encephalopathy, which are critical issues affecting many hospitalized patients, particularly the elderly. Originating as a spin-off from the University Medical Centre Utrecht, Prolira aims to improve patient outcomes through early and objective brain state assessments. The DeltaScan® is the first bedside EEG device that uses a validated algorithm to provide quick and reliable measurements of brain activity. It allows healthcare professionals to identify potential issues before symptoms manifest, enabling timely interventions. The device is portable and user-friendly, making it suitable for routine checks in clinical settings. Prolira has received regulatory approvals, including US FDA clearance and EU MDR certification, and is expanding its presence in the US market while participating in European initiatives to enhance delirium care.

Technologies

Outlook Microsoft Office 365 IoT Deel AI

Keywords

medical devices delirium detection eeg analysis acute encephalopathy healthtech ai healthcare medical equipment manufacturing acute encephalopathy detection brain health monitoring eeg signals hospital care enhancement services brain failure detection postoperative delirium clinical workflow integration neurotoxic treatment support hospital patient monitoring neurodiagnostic device hospital equipment healthcare analytics brain health indicator proprietary algorithms clinical decision support objective brain assessment government patient outcome improvement neurotoxicity monitoring critical care fda-cleared device

Location

8 Padualaan, Utrecht, Utrecht, Netherlands, 3584 CH

Related Companies

Companies in the same industry